111, Inc.
YINASDAQHealthcare● Active
$4.74
$-0.04(-0.84%)
Market Cap$41244257
P/E Ratio—
52W High$11.17
52W Low$2.48
111, Inc.（YI）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · YI · 截至 Jun 9, 2026
关键指标
探索 111, Inc. 数据
yi stock data · financials财务快照
完整财报FY 2025Revenue$12.21B▼ 15.19% YoY
202320242025
111, inc. revenue · yi revenue 2025FY 2025Net Income-$16.8M▲ +73.98% YoY
202320242025
111, inc. net income · yi profit 2025FY 2025EPS$-7.42▲ +1.33% YoY
202320242025
yi eps · 111, inc. earnings per share 2025竞争对手与同行
yi competitors#TickerCompanyPriceChangeMkt Cap
#1YI111, Inc.
$4.74-0.84%$41.2M#2
ANVSAnnovis Bio, Inc.
$1.79-5.29%$35.2M#3
CELUCelularity Inc.
$0.81-6.92%$19.5M#4
DYAIDyadic International, Inc.
$0.70-1.63%$25.5M#5
ECORelectroCore, Inc.
$9.64+10.55%$80.0M#6
ELUTElutia Inc.
$0.99-0.85%$43.8M股票表现
完整历史1D-0.84%
1W-9.89%
1M-21.65%
3M-31.70%
YTD+85.16%
1Y-43.10%
5Y-94.88%
关于 111, Inc.
111, Inc. Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a…
what is 111, inc. · yi stock overview · 111, inc. company profile · who is 111, inc. ceo · yi NASDAQ · 111, inc. headquarters · 111, inc. business segments
关于股票概览与关键数据
111, Inc.（YI）是 Medical - Pharmaceuticals 行业的 Healthcare 类公司，于 Sep 12, 2018 在 NASDAQ 上市。截至最近交易日，YI 股价为 $4.74，市值约为 $41.2M。过去12个月累计回报 -43.10%，年初至今回报 +85.16%。
2025 财年 111, Inc. 营收 $12.2B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，111, Inc.（YI）股价为 $4.74，在 NASDAQ 上市，52周区间为 $2.48 – $11.17。
YI 最新股价YI quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议